---
schema_version: "secwatch.filing_event.v1"
accession: "0001552781-26-000441"
form_type: "8-K"
ticker: "OMER"
cik: "0001285819"
company_name: "OMEROS CORP"
filed_at: "2026-08-13T20:05:44+00:00"
generated_at: "2026-08-13T20:08:47.339371+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Omeros appoints Joseph Schocken to board, expands to nine directors

## Summary
- Board increased to nine directors; Joseph Schocken appointed effective Aug 12, 2026.
- Schocken, 79, founder of Tranceka Capital, joins Audit Committee; term to 2027 annual meeting.
- Granted option for 30,000 shares under non-employee director compensation policy.
- No material interest in transactions requiring disclosure under Item 404(a).

## SEC filing metadata
- accession: 0001552781-26-000441
- form_type: 8-K
- ticker: OMER
- cik: 0001285819
- company_name: OMEROS CORP
- filed_at: 2026-08-13T20:05:44+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285819/000155278126000441/0001552781-26-000441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285819/000155278126000441/e26350_omer-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001552781-26-000441
- JSON: https://secwatch.observer/filing/0001552781-26-000441.json
- Plain text: https://secwatch.observer/filing/0001552781-26-000441.txt

## Key facts
- Executive change
  Joseph Schocken was appointed as Director at OMEROS CORP.
  - Action: appointed
  - Role: Director
  source text: increased the number of its directors to nine and appointed Joseph Schocken as a director, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285819/000155278126000441/0001552781-26-000441-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.